Oze Pharmacy






Oze Pharmacy

Online Pharmacy - Pharmacy Prescription - Pharmaceutical Products - Allergy Sufferers

Mycanadarx Pharmacy - Internet Pharmacy - Healthcare Products - Pharmacy






Packaging Of Pharmaceuticals And Healthcare Products

RRP $237.80

Click on the Google Preview image above to read some pages of this book!

As was the case with Charles Ross's Packaging of Pharmaceuticals published by the UK Institute of Packaging in 1975 it is assumed that the reader of this book already has a broad understanding of the basics of packaging. If not the Packaging Users Handbook and the Handbook of Food Packaging are recommended. The packaging needs of pharmaceuticals are different in degree only from those of other perishable products such as processed foods. Because the required action of a medication can be nullified by any deterioration in its active principles the protection required from its packaging is at least an order of magnitude greater than that needed by foods for example. Functional efficiency is therefore of prime importance. Conversely the need for the packaging to 'sell' the medication is much less, hence the graphics required need only provide the right 'image' for the product when presented for use in hospital or surgery. Even when on sale at the pharmacy the 'appeal' required is that of providing hygiene and confidence more than anything else. Thus, the textual requirements are paramount including traceability (batch numbers, date-coding etc) in case of recall; while striking appearance to attract customer attention is in lower key. And with the increase in malicious tampering nowadays recall is more frequent.


Packaging Pharmaceutical And Healthcare Products

RRP $711.99

Click on the Google Preview image above to read some pages of this book!

As was the case with Charles Ross's Packaging of Pharmaceuticals published by the UK Institute of Packaging in 1975 it is assumed that the reader of this book already has a broad understanding of the basics of packaging. If not the Packaging Users Handbook and the Handbook of Food Packaging are recommended. The packaging needs of pharmaceuticals are different in degree only from those of other perishable products such as processed foods. Because the required action of a medication can be nullified by any deterioration in its active principles the protection required from its packaging is at least an order of magnitude greater than that needed by foods for example. Functional efficiency is therefore of prime importance. Conversely the need for the packaging to 'sell' the medication is much less, hence the graphics required need only provide the right 'image' for the product when presented for use in hospital or surgery. Even when on sale at the pharmacy the 'appeal' required is that of providing hygiene and confidence more than anything else. Thus, the textual requirements are paramount including traceability (batch numbers, date-coding etc) in case of recall; while striking appearance to attract customer attention is in lower key. And with the increase in malicious tampering nowadays recall is more frequent.


Commercialization Of Biopharma Products In The Usa (bw)

RRP $572.99

Click on the Google Preview image above to read some pages of this book!

Commercialization of BioPharma Products in the USA-A Practical Guide (2nd Edition) The discovery, development, and commercialization of a biopharmaceutical product are highly complex processes. The product manufacturing, distribution, and marketing activities must be flawlessly executed to ensure commercial success The commercial environment requires collaboration with diverse stakeholders such as patients, providers, payers, and policy makers to create value for the product. The commercial success of a product is critical in maximizing its potential and the shareholder return. This book outlines commercial imperatives, strategic choices, as well as cardinal imperatives for success along each step of the BioPharma value chain. It shows how pharmaceutical and biotechnology companies can achieve differentiated positioning for their products in this value-driven competitive healthcare environment in the USA. It's intended for anyone involved in commercial decisions in the BioPharma sector.


A Guide To Pharmaceutical Particulate Science

RRP $512.99

Click on the Google Preview image above to read some pages of this book!

The pharmaceutical applications of powder technology have long been recognized. Yet while many books focus on aspects of powder formation and behavior, there has been no text that explores the power of particulate science in the design, manufacture, and control of quality medicines. Until now. A Guide to Pharmaceutical Particulate Science discusses key principles of particulate science and their practical applications. The authors cover particulate material, its form and production, sampling from bodies of powder, particle size descriptors and statistics, behavior of particles, instrumental analysis, particle size measurement and synergy of adopted techniques, physical behavior of a powder, and in vitro and in vivo performance criteria. They draw the components of particulate science into a single concise description of their current and potential uses in product development. Exploring the growth in knowledge of particle properties and the variety of technological advances in particle manufacture, A Guide to Pharmaceutical Particulate Science gives readers the tools they need to grasp the science and its use in the industry.


Structured Financial Products And Financial Engineering

RRP $370.99

Click on the Google Preview image above to read some pages of this book!

For the last decade, the U.S. Senate Permanent Subcommittee on Investigations has presented case histories showing how financial institutions, law firms, accountants, and others have designed and implemented complex financial structures to take advantage of and, at times, abuse or violate U.S. tax statutes, securities regulations, and accounting rules. This book offers yet another detailed case study of how two financial institutions -- Deutsche Bank AG and Barclays Bank PLC -- developed structured financial products called MAPS and COLT, two types of basket options, and sold them to one or more hedge funds, including Renaissance Technologies LLC and George Weiss Associates, that used them to avoid federal taxes and leverage limits on buying securities with borrowed funds.



Search

Oze Pharmacy Articles

Online Pharmacy Pharmacy Prescription Pharmaceutical Products Allergy Sufferers
Mycanadarx Pharmacy Internet Pharmacy Healthcare Products Pharmacy

Oze Pharmacy Books

Online Pharmacy Pharmacy Prescription Pharmaceutical Products Allergy Sufferers
Mycanadarx Pharmacy Internet Pharmacy Healthcare Products Pharmacy

Oze Pharmacy